Uncovering spatial biomarkers in NSCLC to refine immuno-oncology clinical trial strategy

Learn how Tempus’ multimodal platform, combining spatial transcriptomics with genomic and clinical data, helped a biopharma partner identify novel spatial biomarkers to create an actionable patient stratification strategy for an immuno-oncology clinical trial.

May 27, 2026
Life Sciences
Case Study

Related content

Simple white graphic of a single sheet of paper or document, slightly angled.Article
Person works on computer with abstract digital code and data patterns overlayed.

Bridging the gap: How Target Trial Emulation transforms real-world data into credible evidence

2026-08-20
Life Sciences
Simple white graphic of a single sheet of paper or document, slightly angled.Article
Abstract digital background with glowing white lines and a fading dotted pattern.

Q&A: Predicting response and resistance in ADCs with AI and multimodal data

2026-08-20
Life Sciences
Simple white graphic of a single sheet of paper or document, slightly angled.Article
Abstract background with light grey gradient, digital dots, and subtle wave patterns.

Researchers across pharma and academia are reducing oncology drug timelines with Tempus Lens

2026-08-12
Life Sciences